P632: COMPARISON OF TREATMENT-EMERGENT ADVERSE EVENTS OF ACALABRUTINIB AND ZANUBRUTINIB IN CLINICAL TRIALS IN B-CELL MALIGNANCIES: A SYSTEMATIC REVIEW AND META-ANALYSIS
HemaSphere | August 22, 2023 | Volume: 7 | Issue: S3 | Pages: e47546cf
10.1097/01.hs9.0000969432.47546.cf